The biochip market in Latin America is expected to reach a projected revenue of US$ 1,148.6 million by 2033. A compound annual growth rate of 8.5% is expected of Latin America biochip market from 2026 to 2033.
The Latin America biochip market generated a revenue of USD 583.1 million in 2025.
The market is expected to grow at a CAGR of 8.5% from 2026 to 2033.
In terms of segment, dna chips was the largest revenue generating type in 2025.
Lab-on-chip is the most lucrative type segment registering the fastest growth during the forecast period.
Country-wise, Brazil is expected to register the highest CAGR from 2026 to 2033.
Latin America data book summary
Market revenue in 2025
USD 583.1 million
Market revenue in 2033
USD 1,148.6 million
Growth rate
8.5% (CAGR from 2026 to 2033)
Largest segment
Dna chips
Fastest growing segment
Lab-on-chip
Historical data covered
2021 - 2024
Base year for estimation
2025
Forecast period covered
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
DNA Chips, Lab-on-chip, Tissue Arrays, Protein Chips, Cell Arrays
Key market players worldwide
Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox
Other key industry trends
In terms of revenue, Latin America region accounted for 3.8% of the global biochip market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 7,272.5 million by 2033.
The incidence of cancer is growing in this region; however, cancer profiles differ from that in other Western nations. The growing prevalence of cancer is expected to positively influence the regional market over the forecast period.
Moreover, rising demand for personalized healthcare and growing efforts from manufacturers to boost precision medicine are fueling the regional market. Furthermore, several review articles have been published wherein scientists from Mexico, Uruguay, Brazil, Chile, and Argentina are sharing their views on biochip and microarray-based research in each of their countries.
Key initiatives adopted in these countries for the promotion of biochip research are also illustrated in these articles. This, in turn, is expected to boost the development as well as the adoption of biochips in the region.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biochip Market will help companies and investors design strategic landscapes.
Dna Chips was the largest segment with a revenue share of 40.1% in 2025.
Horizon Databook has segmented the Latin America biochip market based on dna chips, lab-on-chip, tissue arrays, protein chips, cell arrays covering the revenue growth of each sub-segment from 2021 to 2033.
The incidence of cancer is growing in this region; however, cancer profiles differ from that in other Western nations. The growing prevalence of cancer is expected to positively influence the regional market over the forecast period.
Moreover, rising demand for personalized healthcare and growing efforts from manufacturers to boost precision medicine are fueling the regional market. Furthermore, several review articles have been published wherein scientists from Mexico, Uruguay, Brazil, Chile, and Argentina are sharing their views on biochip and microarray-based research in each of their countries.
Key initiatives adopted in these countries for the promotion of biochip research are also illustrated in these articles. This, in turn, is expected to boost the development as well as the adoption of biochips in the region.
Latin America Biochip Market Type Outlook (Revenue, USD Million , 2021-2033)
DNA Chips
Protein Chips
Lab-on-chip
Tissue Arrays
Cell Arrays
Latin America Biochip Market End Use Outlook (Revenue, USD Million , 2021-2033)
Biotechnology and Pharmaceutical Companies
Hospitals and Diagnostics Centers
Academic & Research Institutes
Others
Reasons to subscribe to biochips market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of biochips market databook
Our clientele includes a mix of biochips market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America biochips market, including forecasts for subscribers. This continent databook contains high-level insights into Latin America biochips market from 2021 to 2033, including revenue numbers, major trends, and company profiles.